Outlook Therapeutics, Inc. · NASDAQ:OTLK

GMS Ventures & Investments bought 8,539,709 Outlook Therapeutics, Inc. shares (Form 4)

Traded May 28, 2026 · Filed Jun 1, 2026

On May 28, 2026, GMS Ventures & Investments (Director, 10% owner) bought 8,539,709 Outlook Therapeutics, Inc. shares at US$0.59 for US$5.04M, leaving 22,092,068 shares. Filed Jun 1, 2026 (Form 4).

Bought
8,539,709 shares
Price
US$0.59
Value
US$5.04M
Holding after
22,092,068 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 28, 2026Common StockBuy8,539,709US$0.5922,092,068Indirect

Source

View original at SEC

Related